Note: Ingredients listed on restricted chemical lists
EC/CAS
2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
N/A
EC/CAS
2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
N/A
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
N/A
General Information
Revision date
2017-11-02
Product name
TENAS 4IN1
Emergency telephone
+ 49 (0) 89 / 14 33 29 3-10
Icons in SDS
Company Information
company name
Arcora International GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@arcora.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
CLP CLASSIFICATION
Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction.
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard pictograms
GHS07
Signal word
Warning
Contains
2-methylisothiazol-3(2H)-one; 1,2-benzisothiazol-3(2H)-one
Hazard statements
H317 – May cause an allergic skin reaction.
Precautionary statements
P261 – Avoid breathing mist, vapours, spray P280 – Wear protective clothing, protective gloves, eye protection P302+P352 – IF ON SKIN: Wash with plenty of water.
PBT Substances
not relevant – no registration required
vPvB Substances
not relevant – no registration required Component This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII 2-methylisothiazol-3(2H)-one (2682-20-4) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII 1,2-benzisothiazol-3(2H)-one (2634-33-5) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
